Takafumi Yanagisawa - Concepedia

Author

Takafumi Yanagisawa

Jikei University School of Medicine ORCID

Also Known As

Keiichiro Mori, Koichi Aikawa, T Yanagisawa, T. Yanagisawa, TAKAFUMI YANAGISAWA, Takafumi Yanagisawa, Takafumi Yanagisawa*, Y. Takafumi, 柳澤, 孝文

283

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Jikei University School of Medicine Cornell University The University of Texas Southwestern Medical Center Medical University of Vienna Karl Landsteiner Society

About

Takafumi Yanagisawa is an author at Jikei University School of Medicine specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	211
2	Nephrology	2	2	35
3	Public Health	1	1	25
4	Diagnostic Sciences	1	1	25
5	Immunology	1	1	17

Takafumi Yanagisawa

Publications

590

Citations

H-Index

Page 1

	Year	Citations
The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy Koki Obayashi, Jun Miki, Wataru Fukuokaya, International Journal of Clinical Oncology Prognostic EvaluationPrognostic BiomarkersUrologySurgical OncologyRadical Cystectomy	2021	50
Anatomical localization and clinical impact of sentinel lymph nodes based on patterns of pelvic lymphatic drainage in clinically localized prostate cancer Jun Miki, Takafumi Yanagisawa, Shunsuke Tsuzuki, The Prostate	2018	32
Feasibility and accuracy of pathological diagnosis in en‐bloc transurethral resection specimens versus conventional transurethral resection specimens of bladder tumour: evaluation with pT1 substaging by 10 pathologists Takafumi Yanagisawa, Takashi Yorozu, Jun Miki, Histopathology	2020	30
Vertical Lamina Propria Invasion Diagnosed by En Bloc Transurethral Resection is a Significant Predictor of Progression for pT1 Bladder Cancer Takafumi Yanagisawa, Jun Miki, Takashi Yorozu, The Journal of Urology Surgical OncologyPathologyReconstructive UrologyUrogenital RadiologyOncology	2021	25
Functional and oncological outcome of percutaneous cryoablation versus laparoscopic partial nephrectomy for clinical T1 renal tumors: A propensity score-matched analysis Takafumi Yanagisawa, Jun Miki, Kanichiro Shimizu, Urologic Oncology Seminars and Original Investigations Propensity Score-matched AnalysisUrologySurgical OncologyPercutaneous Cryoablation VersusGenitourinary Cancer	2020	23
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer Takafumi Yanagisawa, Takahiro Kimura, Keiichiro Mori, The Prostate	2021	23
Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors Wataru Fukuokaya, Takahiro Kimura, Kazumasa Komura, Urologic Oncology Seminars and Original Investigations UrologyGenitourinary CancerUrothelial CarcinomaMedicineMetronomic Therapy	2022	23
Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study Maximilian Pallauf, David D‘Andrea, Frederik König, The Journal of Urology	2022	23
Do we need repeat <scp>transurethral resection</scp> after <i>en bloc</i> resection for <scp>pathological T1</scp> bladder cancer? Takafumi Yanagisawa, Shun Sato, Yasushi Hayashida, British Journal of Urology	2022	22
Clinical Significance of Horizontal and Vertical Margin of En Bloc Resection for Nonmuscle Invasive Bladder Cancer Takafumi Yanagisawa, Jun Miki, Keigo Sakanaka, The Journal of Urology	2021	21

Page 1